Advertisement

Journal of Hematopathology

, Volume 11, Issue 4, pp 107–113 | Cite as

Post-transplant CD4+ non-cytotoxic γδ T cell lymphoma with lymph node involvement

  • Kristin H. KarnerEmail author
  • Madhu P. Menon
  • Kedar V. Inamdar
  • John L. Carey
Case Report
  • 20 Downloads

Abstract

Gamma delta T cells represent a minor subset of the normal lymphocyte component of the human immune system, largely inhabiting mucosal surfaces. Gamma delta T cell lymphomas (γδ TCLs) are thought to be derived from these cells and are rare, extremely aggressive lymphomas that typically exhibit a cytotoxic phenotype and often present in extranodal sites, most commonly as cutaneous or hepatosplenic subtypes. The immunophenotype usually lacks both CD4 and CD8 expression, but occasional cases express CD8. CD4 expression in γδ TCLs is exceedingly rare. The few reported cases tend to show a non-cytotoxic phenotype with preferential involvement of the lymph nodes. Cases showing cutaneous presentation or with an immunosuppressive clinical history, while relatively common among typical γδ TCLs, are even rarer among this unusual CD4+ subset. While this very small group appears to have an equally dismal prognosis to other types of γδ TCL, little else is known as to how they may differ biologically and whether they should be treated as a separate entity. We report a unique case of CD4-positive gamma delta T cell lymphoma with skin and systemic lymph node involvement in the post-transplant setting.

Keywords

γδ T cell lymphoma Nodal-based γδ T cell lymphoma CD4 Primary cutaneous γδ T cell lymphoma 

Notes

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Esin S, Shigematsuu M, Nagaiu S et al (1996) Different percentages of peripheral blood gamma delta + T cells in healthy individuals from different areas of the world. Scand J Immunol 43:593–596CrossRefGoogle Scholar
  2. 2.
    Kabelitz D (1992) Function and specificity of human gamma/delta T-positive cells. Crit Rev Immunol 11:281–303PubMedGoogle Scholar
  3. 3.
    Khan WA, Yu L, Eisenbrey AB, Crisan D, Saadi AA, Davis BH, Hankin RC, Mattson JC (2001) Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients. Am J Clin Pathol 116:41–50CrossRefGoogle Scholar
  4. 4.
    Swerdlow SH, Campo E, Harris NL et al (eds) (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, IARCGoogle Scholar
  5. 5.
    Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) (2017) WHO classification of tumours of hematopoietic and lymphoid tissues (revised), 4th edn. Lyon, IARCGoogle Scholar
  6. 6.
    Garcia-Herrera A, Song JY, Chuang SS, Villamor N, Colomo L, Pittaluga S, Alvaro T, Rozman M, de Anda Gonzalez J, Arrunategui AM, Fernandez E, Gonzalvo E, Estrach T, Colomer D, Raffeld M, Gaulard P, Campo E, Jaffe ES, Martinez A (2011) Nonhepatosplenic gamma delta T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol 35:1214–1225CrossRefGoogle Scholar
  7. 7.
    Bucy PR, Chen CH, Cooper MD (1989) Tissue localization and CD8 accessory molecule expression of T gamma/delta cell in humans. J Immunol 142:3045–3049PubMedGoogle Scholar
  8. 8.
    Chan JK, Chan AC, Cheuk W et al (2011) Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression. Am J Surg Pathol 35:1557–1569CrossRefGoogle Scholar
  9. 9.
    Ichinohasama R, Miura I, Takahashi T, Yaginuma Y, Myers J, Decoteau JF, Yee C, Kadin ME, Mori S, Sawai T (1996) Peripheral CD4+ CD8- γδ T cell lymphoma: a case report with multiparameter analyses. Hum Pathol 27:1370–1377CrossRefGoogle Scholar
  10. 10.
    Saito T, Matsuno Y, Tanosaki R et al (2002) γδ T-cell neoplasms: a clinicopathological study of 11 cases. Ann Oncol 13:1792–1798CrossRefGoogle Scholar
  11. 11.
    deSouza MHO, Hassan R, Stefanoff CG et al (2007) CD4+ gamma/delta T-cell leukemia/lymphoma: clinical, immunophenotypic and molecular aspects in an unusual case. Haematologica 88:e120–e122Google Scholar
  12. 12.
    Anil R, Grover S, Hiremath A (2016) A rare case of cutaneous gamma delta T-cell lymphoma with complete body involvement. J Med Cases 7:364–367CrossRefGoogle Scholar
  13. 13.
    Vin H, Talpur R, Tetzlaff MT, Duvic M (2014) T-cell receptor-gamma in gamma-delta phenotype cutaneous T-cell lymphoma can be accompanied by atypical expression of CD30, CD4, or TCRbetaF1 and an indolent clinical course. Clin Lymphoma Myeloma Leuk 14:e195–e200CrossRefGoogle Scholar
  14. 14.
    Yabe M, Medeiros LJ, Daneshbod Y, Davanlou M, Bueso-Ramos CE, Moran EJ, Young KH, Miranda RN (2017) Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-alpha inhibitor therapy and literature review. Ann Diagn Pathol 26:16–22CrossRefGoogle Scholar
  15. 15.
    Charton-Bain MC, Brouseet P, Bouabdallah R et al (2000) Variation in the histological pattern of nodal involvement by gamma/delta T-cell lymphoma. Histopathology 36:233–239CrossRefGoogle Scholar
  16. 16.
    Kagami Y, Nakamura S, Ritsurou S et al (1997) A nodal gamma/delta T-cell lymphoma with an association of Epstein-Barr virus. Am J Surg Path 21:729–736CrossRefGoogle Scholar
  17. 17.
    Prillinger KE, Trautinger F, Kitzwogerer M et al (2017) Two faces of gamma-delta mycosis fungoides: before and after renal transplantation. BMJ Case Rep.  https://doi.org/10.1136/bcr-2016-216990
  18. 18.
    Belhadj K, Reyes F, Farcet JP et al (2003) Hepatosplenic gamma delta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 102:4261–4269CrossRefGoogle Scholar
  19. 19.
    Toro JR, Liewehr DJ, Pabby N et al (2003) Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. Blood 101:3407–3412CrossRefGoogle Scholar
  20. 20.
    Willemze R, Jansen PM, Cerroni L et al (2007) Subcutaneous panniculitis-like T-cell lymphoma: definition, classification and prognostic factors. Blood 111:838–845CrossRefGoogle Scholar
  21. 21.
    Foppoli M, Ferreri AJM (2014) Gamma-delta T-cell lymphomas. Eur J Haematol 94:206–218CrossRefGoogle Scholar
  22. 22.
    Kutlu T, Rambaud C, Le Deist F et al (1992) Numbers of T-cell receptor (TCR) ab+ but not of TCR gd+ intraepithelial lymphocytes correlate with the grade of villous atrophy in coeliac patients on a long term diet. Gut 34:208–219CrossRefGoogle Scholar
  23. 23.
    Shigehara K, Shijubo N, Nakanishi F, Hirasawa M, Inuzuka M, Ohmichi M, Hiraga Y, Abe S (1995) Circulating gd-T-cell receptor-positive lymphocytes in sarcoidosis. Respiration 62:84–88CrossRefGoogle Scholar
  24. 24.
    Comoli P, Basso S, Azzi A et al (2003) Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polymoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. J Am Soc Nephrol 14:3197–3204CrossRefGoogle Scholar
  25. 25.
    Merrill ED, Agbay R, Miranda RN, Aung PP, Tetzlaff MT, Young KH, Curry JL, Nagarajan P, Ivan D, Prieto VG, Medeiros LJ, Duvic M, Torres-Cabala CA (2017) Primary cutaneous T-cell lymphomas showing gamma-delta phenotype and predominantly epidermotropic pattern are clinicopathologically distinct from classic primary cutaneous gamma delta T-cell lymphomas. Am J Surg Pathol 41:204–215CrossRefGoogle Scholar
  26. 26.
    Lima M, Canelhas A, Santos C, Teixeira MA, Coutinho J, Alves R, Queirós ML, Fonseca S, Santos AH, Gonçalves V, Massa A, Justiça B (2003) Non-cytotoxic gamma-delta peripheral T-cell lymphoma affecting the mandibular and parotidal lymph nodes and the skin. Leuk Lymph 44:525–529CrossRefGoogle Scholar
  27. 27.
    Spits H, Paliard X, Vendekerckhove Y, van Vlasselaer P, De Vries JE (1991) Functional and phenotypic differences between CD4+ and CD4- T cell receptor-γδ clones from peripheral blood. J Immunol 147:1180–1188PubMedGoogle Scholar
  28. 28.
    Aparicio P, Alonso JM, Toribio ML et al (1989) Isolation and characterization of gamma delta CD4+ T cell clones derived from human fetal liver cells. J Exp Med 170:1009–1014CrossRefGoogle Scholar
  29. 29.
    Vietor H, Koning F (1990) Gamma delta T-cell receptor repertoire in human peripheral blood and thymus. Immunogenetics 31:340–346CrossRefGoogle Scholar
  30. 30.
    Paliard X, Yssel H, Blanchard D et al (1989) Antigen specific and MHC nonrestricted cytotoxicity of T cell receptor alpha beta+ and gamma delta+ human T cell clones isolated in IL-4. J Immunol 143:452–457PubMedGoogle Scholar
  31. 31.
    Ziegler H, Welker C, Sterk M et al (2014) Human peripheral CD4+ Vdelta1+ γδ T cells can develop into alpha beta T cells. Front Immuno 5:645CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Pathology, School of MedicineUniversity of UtahSalt Lake CityUSA
  2. 2.Department of Pathology and Laboratory MedicineHenry Ford Health SystemDetroitUSA

Personalised recommendations